Novo Nordisk has completed multi-billion
Photo: Richard Drew/AP/TT

Novo Nordisk has completed multi-billion dollar acquisition

Danish pharmaceutical giant Novo Nordisk has completed the acquisition of biotechnology company Akero Therapeutics, which was first announced in early October.

Advertisement

The price tag will be $54 per share, which corresponds to a market capitalization of $4.7 billion, approximately 44 billion Swedish kronor, according to a press release from Novo Nordisk.

In recent years, Novo Nordisk has become best known for the weight loss drugs Wegovy and Ozempic, which have made the company one of Europe's largest by market capitalization.

AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All